Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations.
about
Society of Gynecologic Oncology recommendations for the prevention of ovarian cancerThe disparate origins of ovarian cancers: pathogenesis and prevention strategies.A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group studyA novel BRCA2 mutation in an Indonesian family found with a new, rapid, and sensitive mutation detection method based on pooled denaturing gradient gel electrophoresis and targeted sequencing."Back to a false normality": new intriguing mechanisms of resistance to PARP inhibitorsTumors that mimic asbestos-related mesothelioma: time to consider a genetics-based tumor registry?Hereditary Breast-Ovarian Cancer Team of the University Medical Centre Groningen (UMCG) - a ReportMolecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer.Emerging roles of BRCA1 alternative splicing.Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy.Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.10 rare tumors that warrant a genetics referral.Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.Cancer risk assessment for the primary care physician.The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers.The fallopian tube: from back stage to center stage.Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.Asymptomatic primary fallopian tube cancer: an unusual cause of axillary lymphadenopathySurveillance of women at high risk for hereditary ovarian cancer is inefficient.Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004.Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations.Pathogenesis and heterogeneity of ovarian cancer.Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition.Clear cell and endometrioid carcinomas: are their differences attributable to distinct cells of origin?Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery.Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention.FANCD2 protein is expressed in proliferating cells of human tissues that are cancer-prone in Fanconi anaemia.Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.Survival and prognostic factors of patients with primary fallopian tube cancer receiving adjuvant paclitaxel and carboplatin chemotherapy.Primary transitional cell carcinoma of the fallopian tube.A meta-analysis of biomarkers for the prognosis of triple-negative breast cancer patients.HER-2/neu and p27Kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study.Ki-67 and p53 expression of the fallopian tube mucosa in breast cancer patients with hereditary risk.Pathology of hereditary breast cancer.Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube.
P2860
Q27009306-C1162FD6-85F9-4EFD-81D8-20325712C4D4Q30240709-4931B433-CCE4-4A9C-B868-9FC913086428Q30431721-D233F938-B46D-47D7-8DD4-E2F4113F6429Q33214483-8323E877-FC62-48E6-B9D7-133A3A951167Q33618910-ADFFD85C-7481-490B-A2A7-4AD7803100C2Q33687535-CBDEF327-95FC-4145-96E5-B013609C486BQ33721575-1A50FDE0-02ED-4A63-B4A3-F149D8E0D11CQ33919065-D3CCD42B-C050-4573-A245-AF05E67BAAA7Q33919195-8B918E3F-9998-40DF-A36B-FFE35EE55BC1Q34126089-471BF630-B4C8-44B9-A05B-4B18FAF01070Q34313361-9F5DCF45-D8AF-4101-B5D2-70ECD7EA8848Q34325954-E538A016-7126-4A5C-8767-20FE2253E2C0Q34519901-0890F348-618F-420E-9A57-38AECCDC4203Q34977063-E6658904-B5E4-46E6-B830-222D3539C7DFQ34992880-D87C8886-B599-4024-8706-EFC3AD4F76D6Q35018746-7AE41F65-D12F-4B18-8A95-A79004AC764DQ35562911-B4E647A1-CC68-4887-9C8B-FBF0F4648D8AQ35758403-5AD27D6F-84C5-4A26-A832-3B8B958B6F05Q35910080-107B6285-1D71-47F4-B036-D6C0D089D1F5Q36614506-DE012E90-2A9F-4C45-8DCC-264C3C9C3135Q37252742-554A276C-A67C-4172-97BD-B03F39B309A9Q37356474-8A1681FF-C240-49BF-863D-C9E9A5F00575Q37546692-50A80E58-A3FC-4E20-BADD-5B5596122DA9Q38451794-3DD11431-23FE-4B0A-A17F-EE627B605656Q38693040-FD863E26-C0A4-42DF-BDAA-26C819EC5B92Q38732720-1017F329-C103-42AA-B278-4E58AE029737Q39441988-9E0C40D9-906C-4CAB-B1FD-EA5F4E758036Q40630222-9FB4614C-EB51-46FD-ACF8-6D2A06990BBAQ43625600-04F7ADC8-41D9-49C7-B98E-B4D155838A67Q50697654-BA39627C-F6B9-4BC3-BE16-AB737E57BBB7Q51434193-4132545B-EB34-4477-98E0-CCFB48B87E65Q51684386-EF4D33C6-6F99-4F94-93E9-CCE7D4C0A516Q54005783-C95F7E58-9DE2-4027-A354-FDE1B0869947Q54653872-63FC02FF-4B5A-4706-8477-C10DA6F70ADCQ55110010-7ED32BD4-EBC1-48CE-B252-4F1C4DAC5732Q55397998-BBFB344C-A0D6-4FCE-BB17-E27F2C603BF5
P2860
Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Molecular evidence linking pri ...... e to BRCA1 germline mutations.
@ast
Molecular evidence linking pri ...... e to BRCA1 germline mutations.
@en
Molecular evidence linking pri ...... e to BRCA1 germline mutations.
@nl
type
label
Molecular evidence linking pri ...... e to BRCA1 germline mutations.
@ast
Molecular evidence linking pri ...... e to BRCA1 germline mutations.
@en
Molecular evidence linking pri ...... e to BRCA1 germline mutations.
@nl
prefLabel
Molecular evidence linking pri ...... e to BRCA1 germline mutations.
@ast
Molecular evidence linking pri ...... e to BRCA1 germline mutations.
@en
Molecular evidence linking pri ...... e to BRCA1 germline mutations.
@nl
P2093
P356
P1433
P1476
Molecular evidence linking pri ...... e to BRCA1 germline mutations.
@en
P2093
Kenemans P
Sijmons RH
Verheijen RH
Zweemer RP
van Diest PJ
P356
10.1006/GYNO.1999.5623
P407
P577
2000-01-01T00:00:00Z